Latest articles

Bayer, Monsanto confirm spending plans after meeting Trump

Same total R+D budget, at least half to be spent in U.S.

Frankfurt | Reuters –– Bayer and Monsanto said Tuesday they would spend at least half of their agriculture research and development budget in the U.S. over the next six years, following a meeting with U.S. president-elect Donald Trump last week.

The two companies, which are awaiting approval of their agreed US$66 billion deal from Trump’s incoming administration, issued a joint statement after Trump’s spokesman said Bayer had pledged to boost U.S. investments and jobs.

They said they expect to spend a total of about $16 billion worldwide on agriculture R+D over the next six years, in line with an annual 2.5 billion-euro (C$3.5 billion) pro-forma budget they announced at the time of the merger agreement in September.

The German drugs and agriculture group and the U.S. seeds giant also said on Tuesday they would create “several thousand new high-tech, well-paying jobs after integration is complete.”

Trump’s spokesman had said the companies had promised to maintain their more than 9,000 U.S. jobs and add 3,000 new U.S. high-tech positions.

Trump has elicited jobs and investment pledges from several companies including General Motors and Wal-Mart as he prepares to take office on Friday.

Reporting for Reuters by Ludwig Burger; writing by Andreas Cremer.

explore

Stories from our other publications

Comments

  • Rob Bright

    Trump needs to do the same thing with the agrochemical/ biotech industry that he did with the pharmaceutical industry — demand real scientific research into the safety of these products first!

    • patzagame

      Hope he makes a safety committee like he’s doing for vaccines.

  • grinninglibber

    And if they don’t? Crickets…